Journal of Renal Injury Prevention
Published by Nickan Research Institute
eISSN : 2345-2781
Abbreviation : J. Ren. Inj. Prev.
Aims & Scope
The Journal of Renal Injury Prevention (JRIP) is a quarterly peer-reviewed international journal devoted to the promotion of early diagnosis and prevention of renal diseases.
It publishes in March, June, September and December of each year.
It has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views and renal biopsy teaching point.
In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of renal failure and modalities in the treatment of diabetic nephropathy.
A further aim of this journal is to emphasize and strengthen the link between renal pathologists/nephropathologists and nephrologists.
In addition, JRIP welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical nephrology.
Futuristic conceptual hypothesis that integrate various fields of acute kidney injury and renal tubular cell protection are encouraged to be submitted.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 0.2 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 24097 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 29 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.156 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q4 |
h-index
| Year | Value |
|---|---|
| 2024 | 15 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.